Adipose Tissue-Derived Mesenchymal Stem Cells Have a Heterogenic Cytokine Secretion Profile

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2017 Jun 24

PMID 28642794

Citations 30

Authors

Yongkang Wu

Martin J Hoogduijn

Carla C Baan

Sander S Korevaar

Ronella de Kuiper

Lin Yan

Lanlan Wang

Nicole M van Besouw

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stem cells derived from adipose tissue (ASC) have immune regulatory function, which makes them interesting candidates for cellular therapy. ASC cultures are however heterogeneous in phenotype. It is unclear whether all ASC contribute equally to immunomodulatory processes. ASC are also responsive to cytokine stimulation, which may affect the ratio between more and less potent ASC populations. In the present study, we determined IL-6 receptor (CD126 and CD130 subunits) and IFN- receptor (CD119) expression on ASC by flow cytometry. The production of IL-6 and IFN- was measured by ELISA and the frequency of IL-6 and IFN- secreting cells by ELISPOT. The results showed that ASC did not express CD126, and only 10-20% of ASC expressed CD130 on their surface, whereas 18-31% of ASC expressed CD119. ASC produced high levels of IL-6 and 100% of ASC were capable of secreting IL-6. Stimulation by IFN- or TGF- had no effect on IL-6 secretion by ASC. IFN- was produced by only 1.4% of ASC, and TGF- significantly increased the frequency to 2.7%. These results demonstrate that ASC cultures are heterogeneous in their cytokine secretion and receptor expression profiles. This knowledge can be employed for selection of potent, cytokine-producing, or responsive ASC subsets for cellular immunotherapy.

Citing Articles

Enhancement the antioxidative and immunomodulatory functions of mesenchymal stem cells by tetrandrine.

Fadaghi S, Mahmoodi M, Derakhshani A, Sedghy F, Ranjkesh M, Behzadi A Heliyon. 2024; 10(16):e35667.

PMID: 39220890 PMC: 11365297. DOI: 10.1016/j.heliyon.2024.e35667.

Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities.

Zhidu S, Ying T, Rui J, Chao Z Stem Cell Res Ther. 2024; 15(1):266.

PMID: 39183341 PMC: 11346273. DOI: 10.1186/s13287-024-03885-z.

Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review.

Hetta H, Elsaghir A, Sijercic V, Akhtar M, Gad S, Moses A Health Sci Rep. 2024; 7(4):e2036.

PMID: 38650719 PMC: 11033295. DOI: 10.1002/hsr2.2036.

Cytokine production by bovine adipose tissue stromal vascular fraction cells upon Neospora caninum stimulation.

Oliveira B, Sidonio B, Correia A, Pinto A, Azevedo M, Sampaio P Sci Rep. 2024; 14(1):8444.

PMID: 38600105 PMC: 11006870. DOI: 10.1038/s41598-024-58885-z.

Enhancing Immunomodulatory Function of Mesenchymal Stromal Cells by Hydrogel Encapsulation.

Cheng H, Anggelia M, Liu S, Lin C, Lin C Cells. 2024; 13(3.

PMID: 38334602 PMC: 10854565. DOI: 10.3390/cells13030210.

References

Deng Y, Yi S, Wang G, Cheng J, Zhang Y, Chen W . Umbilical cord-derived mesenchymal stem cells instruct dendritic cells to acquire tolerogenic phenotypes through the IL-6-mediated upregulation of SOCS1. Stem Cells Dev. 2014; 23(17):2080-92. DOI: 10.1089/scd.2013.0559. View

Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. DOI: 10.1634/stemcells.2005-0342. View

Gerrits J, van de Wetering J, Weimar W, van Besouw N . T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients. Transplantation. 2009; 87(6):907-14. DOI: 10.1097/TP.0b013e31819b3df2. View

Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D . Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood. 2004; 103(12):4619-21. DOI: 10.1182/blood-2003-11-3909. View

Sivanathan K, Rojas-Canales D, Hope C, Krishnan R, Carroll R, Gronthos S . Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function. Stem Cells. 2015; 33(9):2850-63. DOI: 10.1002/stem.2075. View

Mo M, Wang S, Zhou Y, Li H, Wu Y . Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential. Cell Mol Life Sci. 2016; 73(17):3311-21. PMC: 11108490. DOI: 10.1007/s00018-016-2229-7. View

Anderson P, Souza-Moreira L, Morell M, Caro M, OValle F, Gonzalez-Rey E . Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis. Gut. 2012; 62(8):1131-41. DOI: 10.1136/gutjnl-2012-302152. View

James S, Fox J, Afsari F, Lee J, Clough S, Knight C . Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes. Stem Cell Reports. 2015; 4(6):1004-15. PMC: 4471830. DOI: 10.1016/j.stemcr.2015.05.005. View

De Witte S, Lambert E, Merino A, Strini T, Douben H, OFlynn L . Aging of bone marrow- and umbilical cord-derived mesenchymal stromal cells during expansion. Cytotherapy. 2017; 19(7):798-807. DOI: 10.1016/j.jcyt.2017.03.071. View

10.

Li P, Tian H, Li Z, Wang L, Gao F, Ou Q . Subpopulations of Bone Marrow Mesenchymal Stem Cells Exhibit Differential Effects in Delaying Retinal Degeneration. Curr Mol Med. 2016; 16(6):567-81. DOI: 10.2174/1566524016666160607090953. View

11.

Roemeling-van Rhijn M, Khairoun M, Korevaar S, Lievers E, Leuning D, IJzermans J . Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive and in a Humanized Allograft Rejection Model. J Stem Cell Res Ther. 2014; Suppl 6(1):20780. PMC: 3963708. DOI: 10.4172/2157-7633.S6-001. View

12.

Kuci Z, Seiberth J, Latifi-Pupovci H, Wehner S, Stein S, Grez M . Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression. Haematologica. 2013; 98(10):1609-16. PMC: 3789467. DOI: 10.3324/haematol.2013.092700. View

13.

Ertas G, Ural E, Ural D, Aksoy A, Kozdag G, Gacar G . Comparative analysis of apoptotic resistance of mesenchymal stem cells isolated from human bone marrow and adipose tissue. ScientificWorldJournal. 2012; 2012:105698. PMC: 3349309. DOI: 10.1100/2012/105698. View

14.

Kim H, Yun J, Shin T, Lee S, Lee B, Yu K . Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-β1 alleviate atopic dermatitis by reducing mast cell degranulation. Stem Cells. 2014; 33(4):1254-66. DOI: 10.1002/stem.1913. View

15.

Mabuchi Y, Morikawa S, Harada S, Niibe K, Suzuki S, Renault-Mihara F . LNGFR(+)THY-1(+)VCAM-1(hi+) cells reveal functionally distinct subpopulations in mesenchymal stem cells. Stem Cell Reports. 2013; 1(2):152-65. PMC: 3757748. DOI: 10.1016/j.stemcr.2013.06.001. View

16.

Zuk P, Zhu M, Mizuno H, Huang J, Futrell J, Katz A . Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001; 7(2):211-28. DOI: 10.1089/107632701300062859. View

17.

Nasef A, Zhang Y, Mazurier C, Bouchet S, Bensidhoum M, Francois S . Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. Int J Lab Hematol. 2009; 31(1):9-19. DOI: 10.1111/j.1751-553X.2007.00997.x. View

18.

Deng Y, Zhang Y, Ye L, Zhang T, Cheng J, Chen G . Umbilical Cord-derived Mesenchymal Stem Cells Instruct Monocytes Towards an IL10-producing Phenotype by Secreting IL6 and HGF. Sci Rep. 2016; 6:37566. PMC: 5137158. DOI: 10.1038/srep37566. View

19.

Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C . Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol. 2005; 129(1):118-29. DOI: 10.1111/j.1365-2141.2005.05409.x. View

20.

Jin H, Bae Y, Kim M, Kwon S, Jeon H, Choi S . Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci. 2013; 14(9):17986-8001. PMC: 3794764. DOI: 10.3390/ijms140917986. View